Profound Medical Corp. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PROF, updated each market day.
PROF AI Sentiment
AI predicts Profound Medical Corp. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Profound Medical Corp. Common Stock
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Sector
Exchange
Market Cap
$215,222,620
Cap Tier
Employees
162
Headquarters
MISSISSAUGA, A6
Listed Since
May 9, 2016
Website
PROF Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PROF Volatility
Profound Medical Corp. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
